Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Sep 23, 2025 (13 months ago)

Sting Relief Swabs

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Product Mix-up

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Sting Relief Swabs, First Aid Only, 10 Swabs per box, part number 19-001, Manufactured for: Acme United Corporation, 1 Waterview Dr. Shelton, CT, Made in the USA UPC 738743190015

Recalling firm
Acme United Corporation
Origin
CT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0122-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Acme United Corporation

All 2025 recalls
Class II · Moderate risk

Dynarex

CGMP Deviations

Ongoing cGMP deviation Acme United Corporation NDC 67777-245-04 D-0376-2026
Class II · Moderate risk

Dynarex

CGMP Deviations

Ongoing cGMP deviation Acme United Corporation NDC 67777-245-01 D-0375-2026

Other labeling / mix-up recalls from 2025

All labeling / mix-up recalls
Class II · Moderate risk

Levothyroxine Sodium Tablets

Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Ongoing Labeling / mix-up Alvogen, Inc D-0259-2026
Class III · Low risk

parodontax

Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.

Ongoing Labeling / mix-up Haleon US Holdings LLC NDC 0135-0651-02 D-0297-2026
Class I · High risk

POTASSIUM CHLORIDE Inj.

Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq

Ongoing Labeling / mix-up Otsuka ICU Medical LLC NDC 0990-7074-26 D-0181-2026